About DB Ashbourne
DB Ashbourne is a Healthcare company based in United Kingdom founded in 2010, and was acquired by Ethypharm in October 2015. Procurement platform for generic medicines is provided by DB Ashbourne. The company has 3 employees. Its chief executive, as recorded, is Bertrand Deluard. The company was acqui-hired. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its legal entity is ORPHEA LIMITED.
Company details
DB Ashbourne, established in 2010 and currently in Acqui-Hired stage, focuses on healthtech, healthcare it, provider, administrative solutions, materials management, procurement, and generic. Provider of procurement platform of generic medicines. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters United Kingdom
- Employees 3
- Stage Acquired
- SectorsHealthcare
- Website dbashbourne.com
- Acquired by Ethypharm (Oct 2015)
- Legal Name Orphea Limited
- Date of Incorporation 08 Apr, 2016
- Jurisdiction ROMFORD, ESSEX
Investors in DB Ashbourne
DB Ashbourne has secured backing from 1 investor. Prominent investors backing the company include Ethypharm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapies for pain and addiction treatment are developed. | 1977 | ethypharm.com | Saint Cloud, France |
Investor details for DB Ashbourne
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DB Ashbourne
1 people are tracked at DB Ashbourne (1 in leadership); the tracked headcount is 3.
| Name | Role | Group |
|---|---|---|
Bertrand Deluard | CEO | Leadership |
Complete people profiles for DB Ashbourne
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DB Ashbourne
2 dated milestones of DB Ashbourne across 5 years, from founding to its latest funding, stage changes and deals.
- Founded DB Ashbourne is founded.
- Exit Acquired by Ethypharm.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Db Ashbourne
Complete news archive for DB Ashbourne
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DB Ashbourne
DB Ashbourne was founded in 2010.
DB Ashbourne is headquartered in United Kingdom.
Bertrand Deluard is the CEO of DB Ashbourne, as recorded in our data.
DB Ashbourne has 3 employees.
DB Ashbourne, established in 2010 and currently in Acqui-Hired stage, focuses on healthtech, healthcare it, provider, administrative solutions, materials management, procurement, and generic. Provider of procurement platform of generic medicines. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
DB Ashbourne has 1 investor. Key investors include Ethypharm.
DB Ashbourne operates through Orphea Limited.
Yes. DB Ashbourne was acquired by Ethypharm in October 2015.